Novick A - Search Results

1

Tumor-induced suppression of T lymphocyte proliferation coincides with inhibition of Jak3 expression and IL-2 receptor signaling: role of soluble products from human renal cell carcinomas.

Kolenko V, Wang Q, Riedy MC, O'Shea J, Ritz J, Cathcart MK, Rayman P, Tubbs R, Edinger M, Novick A, Bukowski R, Finke J. Kolenko V, et al. Among authors: novick a. J Immunol. 1997 Sep 15;159(6):3057-67. J Immunol. 1997. PMID: 9300731

2

Effect of renal cell carcinomas on the development of type 1 T-cell responses.

Rayman P, Wesa AK, Richmond AL, Das T, Biswas K, Raval G, Storkus WJ, Tannenbaum C, Novick A, Bukowski R, Finke J. Rayman P, et al. Among authors: novick a. Clin Cancer Res. 2004 Sep 15;10(18 Pt 2):6360S-6S. doi: 10.1158/1078-0432.CCR-050011. Clin Cancer Res. 2004. PMID: 15448031

3

GM2 expression in renal cell carcinoma: potential role in tumor-induced T-cell dysfunction.

Biswas K, Richmond A, Rayman P, Biswas S, Thornton M, Sa G, Das T, Zhang R, Chahlavi A, Tannenbaum CS, Novick A, Bukowski R, Finke JH. Biswas K, et al. Among authors: novick a. Cancer Res. 2006 Jul 1;66(13):6816-25. doi: 10.1158/0008-5472.CAN-06-0250. Cancer Res. 2006. PMID: 16818659

4

Phase II trial of interleukin-2 and interferon-alpha in patients with renal cell carcinoma: clinical results and immunologic correlates of response.

Bukowski RM, Olencki T, Wang Q, Peereboom D, Budd GT, Elson P, Sandstrom K, Tuason L, Rayman P, Tubbs R, McLain D, Klein E, Novick A, Finke J. Bukowski RM, et al. Among authors: novick a. J Immunother. 1997 Jul;20(4):301-11. doi: 10.1097/00002371-199707000-00007. J Immunother. 1997. PMID: 9220320 Clinical Trial.

5

Defective granzyme B gene expression and lytic response in T lymphocytes infiltrating human renal cell carcinoma.

Kudoh S, Redovan C, Rayman P, Edinger M, Tubbs RR, Novick A, Finke JH, Bukowski RM. Kudoh S, et al. Among authors: novick a. J Immunother. 1997 Nov;20(6):479-87. doi: 10.1097/00002371-199711000-00008. J Immunother. 1997. PMID: 9409454

6

Impaired activation of NFkappaB in T cells from a subset of renal cell carcinoma patients is mediated by inhibition of phosphorylation and degradation of the inhibitor, IkappaBalpha.

Ling W, Rayman P, Uzzo R, Clark P, Kim HJ, Tubbs R, Novick A, Bukowski R, Hamilton T, Finke J. Ling W, et al. Among authors: novick a. Blood. 1998 Aug 15;92(4):1334-41. Blood. 1998. PMID: 9694722 Free article.

7

Interferon-gamma production by T lymphocytes from renal cell carcinoma patients: evidence of impaired secretion in response to interleukin-12.

Ulchaker J, Panuto J, Rayman P, Novick A, Elson P, Tubbs R, Finke JH, Bukowski RM. Ulchaker J, et al. Among authors: novick a. J Immunother. 1999 Jan;22(1):71-9. doi: 10.1097/00002371-199901000-00010. J Immunother. 1999. PMID: 9924702

8

Clinical practice guidelines: renal cell carcinoma.

Bukowski RM, Novick AC. Bukowski RM, et al. Among authors: novick ac. Cleve Clin J Med. 1997;64 Suppl 1:SI1-44; quiz SI45-7. doi: 10.3949/ccjm.64.s1.4. Cleve Clin J Med. 1997. PMID: 9239949 Free article. Review.

9

Mechanisms of apoptosis in T cells from patients with renal cell carcinoma.

Uzzo RG, Rayman P, Kolenko V, Clark PE, Bloom T, Ward AM, Molto L, Tannenbaum C, Worford LJ, Bukowski R, Tubbs R, Hsi ED, Bander NH, Novick AC, Finke JH. Uzzo RG, et al. Among authors: novick ac. Clin Cancer Res. 1999 May;5(5):1219-29. Clin Cancer Res. 1999. PMID: 10353760

10

Dead or dying: necrosis versus apoptosis in caspase-deficient human renal cell carcinoma.

Kolenko V, Uzzo RG, Bukowski R, Bander NH, Novick AC, Hsi ED, Finke JH. Kolenko V, et al. Among authors: novick ac. Cancer Res. 1999 Jun 15;59(12):2838-42. Cancer Res. 1999. PMID: 10383143

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

676 results

Search Page